<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Simvastatin improves survival in cardiac transplant recipients</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Simvastatin improves survival in cardiac transplant recipients</h1>
<div class="graphic"><div class="figure"><div class="ttl">Simvastatin improves survival in cardiac transplant recipients</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAcUAAAGGCAMAAAA902p0AAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAVFBMVEX/////AwMGN//AwMACAgJDQ0O+y/+AgID/gICAmf8oKChFav//Q0PY2Njz8fT/wMCgoKBwcHCQkJCwsLBgYGD+Jyj/p6f+aGnV3f//2Nigs/9/GX92G90lAAANvUlEQVR42uydiXbiOgxADbGzOInZw/L+/z+f5LSdttCZtgSIw71naNiHcmtZUjZjAAAAAAAAAAAAAAAAAAAAAADgsWQZ30H6FAXfARbhXkGzlR9hWSyDLDfFusVicrSFdbLw1llvzMp6a1sspoazanEjP5zdBGvN2q4uWFyUyoLva6wBVS0WttCLXo+3s+IF987iflfydSVtUan+w+KoLWoYXdl1K3PjJs6Tl+ZFLI43u1lbnwXRl3lJa7zdOLvEYoLZjbWZWXrrxV4rKerKYHHCVT8W+0RPCJceaPbn9x2b7uy+rjli8dHMlO7SA80Fixeqs3K2eKjFprwXizFbNJ0IO+6bZh9MV3aNjq2y2avFstHBt9A7QylX1WL8hUzoHzo2TfNQi6f6bhKbctQWy9neLJpyL4tmttvNdkYUlmJR7mlknJaz2S7+Oy5mpWkauWZ2s3I3Ox5ns/KxFsM83Ou/LctxR9SdfBOdCGvEohFBRkRqRJVFkIXGzH6hFvUJok+tl2V0/EiLpj5hUS3u1aIMu8WLRbloNFWL/eKTxf3saOS5OlHoIw+2mOdYjBG1H4Rd98fi262uFG8fLapvuT3rZLoUmYvHRtQ7MnKLMrt1cmn+WDzu4q3QyEg1nyzGpFbSGgnEnSiV+RKLcK3FvMqxmLzFQ13P6/oOJstmIsXlGC3G8VhXd+hyTaW4HKtF0Tiyz/io8Ltvbv2CW2Y38+ez2Bfvn+jKH7xKK8muHJHFOn86i9pgM2Hf7Pu1EXJNbquUsiub7tg0IZTaNJVKoolPKnURX9U12j/tZrvyKC+Qp+zvPwNctFg9ncXdbNe8dEL7m+V+F0vFvmG6kyJxp+3VzuzKfWyr7svdIr6q2eurpExspGKU4Sl15cU1Ive2mD/fWNTYeBRVXR8jpbQvj73Fd+22rpkFs9g3fXNHMucYUY9ls+ufYaLF8vVNpl/136AsWVxr8fVidPWSrq/4aFEkR81NJ6My7HfacYvud93+o8UFFn9bllw3GS1EjpntFk0fUZtOr320KCE1drpLtbgvF/tZqa96bZzKi4/jsji2kHqHsKth8rjTRujLLbn2yWKna6fCTmdJXcGo/VR91UvjtOwH74gsnuqnszi5qt+YwxyL6Vs091vpj8XbWaxzLKZvsaqwmL7FvMZi+hZDeulNeb9tace3TvSLqn9+SM3iosTiBCbGZ+YLiyl2b7AIWISRWiSkTsFiVfPdpG8xxYY4Fs8rxsCXk77FmolxAhap+6dg8UR6MwGLgfRmClV/eg1xLF6qGHPdofGNi7dIgUZuMa/+bbEmBRq5xe9AIotFwCJgEYs/zGNfr8NILX4nj42QzI7YIqH3qSyy6cAULAIWgYiKRbIbLL4vLCkaJxBRKRqnkt0QVrEI47BIokq9CFicBCFTgokLImqiZLY/DWNcPCy7qf+9HvL9rRPezsbiUk/xLiYfOBarn1mco/GMrd0aseicWrx4dumxcULjZ1odisYV27hMwiIaLw9FxdksmRz1hMXP6Y0OQa9jMVBpJIqLpwbXU4T7Nql6MWc4TqDqz9l3awIWJcXhCAPpWzR1jcb0LYpGPKVvMaBxAhZNoPqfgEVzmLM6JH2LsWr81r5Zf72VY/HxJq+1ON1t8J6pA5czFgGLgEUiKhbfqMhupmCx/kFSm2Nx5KXKNyymVZWQ3Uwh+mIRi1jEIhaxiEUsfqNDcDGNzbGYaGHyzuJICxAsTiHQYhGLWMRimknPTXE9KyymjO1xWHxCsDiqiGpMWBdFscTiTbObfx1g4mrLjoh6x07AZYvXdwXsymY/3k0fiyOrRGxm24KxmLrFpfNE1NQtLpf90VCwmLLFX+1xi8WRVSLOLwMWx5HF/l7mSgqNbYbFtC2asHFkN6nTrrx9PUwYFlPFWb/6aYqKxbGx3pCjPilYHBU2oxs+VM2X5xdLtkut7kN9fhCXU/3rQ9e5dsW6/kGYK5dKhfmFgycdLhQV1TXHdaF3M5RFcxJhh7quq2BOVV7r2KrqWi3KIq6FkjtDJeNQLcYK0YT+IX3ZNRbp3QxmsRJheV2pt3o+r/t79M5qXqmjKt4p/w75vDLqbS5PlIcOh3n/jF9D72a4iKqHgTzVvUWjF9GkEVX+hSgzN/1CLeoTRJ9ajyceuCqi0rsZyqIMtaDDLn9nsX61aM4tikQjz9XOWxVH6hUW6d0MFlH7QZif/lh8uyWeqk8W5dm53J6f8uokMvPr5kV6N0NZlNntdNCJ783iy60gM2BlPlmMSa2kNTG1jVPmFRbp3UyB1QqL6bN1WEyftWWr4vShjzoSqmsOc97qGTLZBm5oJf9OODWN/dvtH7EsiKiDI/WDdktjS1XRbmnfMz1oD1U36c+l+Mjz6nDKTa4PXmeRiHoLi1L+VYe+idqPs6p67ZnmsZV6OsniJGVi7PVUsQtwZUS1jMUbRNT+cohSRebhMNcRWOX9IlqLgbeeh77Pc22Gw1i8mUWdH/vmd/6lRXO1RZkXV0TU4S1WuYzAfN6r0W5pLT/zul8r1VvMD9Hiuwb6dfPiBovDT4xGp77Da7YT1yCLzdchGdObfqhWcZ3W1fPil4WGViGZpFjL4uOqZCyOjOUyuC9XTMVDNxjjrbMeiyPGr7fWrr+0qGNxI/Om06ibxjnCnxGbebdyX1p0LjOFLeIFi+O1KH6+3CPc6cnB2zeLRNSxspKo6bd/y2GztV3J09ZYHC9hvQnFF0lq5nUshtb6zH/YaxyLCdF6a73YW3rrl+SoUwOLWITho2bbX7CYMlr6ceypxEeis96xhX/iZP1RblmnkXrVvyS7mULVz9ZTE8hu2HpqAljP9qjp438jBItjy2488yLzIoyi7mc/jSmwKdoCi6nPi9ZmjqMzpF5pbH1GNzx5i5nLtlhMPUf13n25PSoWU8lRpdDwAYsTqDSwmDjemeDJUZPPbthiYwIW1+xLnD5b6z379adO2Fr740PBYXFsOWr7ixdhcWxVP0fzmwAbj8UJjEXWEk8AzorytGBxbDmqt5lnnUbieGuzFfNi4tiNY11/+hbXbsM6jeQTFa00OM9U6qyd+/GJUbA4MjL6qMkT/M8bN1gcG8vfrF3E4thyG/+rfd+wODKLReEde75NoM5gnUbqGWp/1FrG4lMOYSxiEbAIWAQsYhGwCFgELGIRsAhYBCxiEbAIWIRPtOtiHd5OMo3FNNFdVP3bSaaxmCabELzNXk4yjcV00ZOg9ieZ5uzSyaLnJH45yTQWU2Vlt68zZEZETTa78UWRvZxkGouJEpPT4vUk01ik6gcsAhYBi1gELAIWAYtYBCwCFgGLWAQsAhYBi1gELAIWAYtY5DvAImARsAhYxCJgEbAIWMQiYBGwCFjEImARsAhYxCJgEbAIWMQiYBGwCFjEImARsAhYBCxiEbAIWAQsYhGwCFgELGIRsAhYBCxiEUZLWBbLgMXE8dbpCd+xmDIb64yzGyymPQvaIl6wOAmLnOk9YdZ2ZVZ2jcWkaa3PvG2JqGmz9NYvyVGp+gGLgEXAIhYBi3Bji66A25Ld3mL2539zwwt1t/gbSeRzvr1nlnpwvUm8TuRzPmiuwiIWsYhFLGIRi1jEIhaxiMUbNACyFN4ymc+ZZQYAAAAeytmOOAPQrov10O9p2qy9yW9fDP2Gw//q/+ZsR5wBcNYO/p6ttcPn8PKmbtAPGvTrtHfXeL4jzhBvGuS3yYb+a7uBxY+bWg9RZ8hfr7N3LzbOd8QZ5/dT2NXwn7K1XsbOwGPR+62ZiEXdM2TY73tzg0+ZxT0flkNa3FrxePeI+rYjzqCs7HboPzalGHwsuoH/hNfybs7evQl3viPOINmNH3i7kzbLtnY7eJLq7WbYCXw5+Oj+5v/7eUecAbjJwLnF7N1KzjTsL7+S7JytRAEAAAAAAAAAAAAAAAAAIDEy3fz3e9sAb9z/7ZzbiuswDEUNlhAYHHz7/28dXeycdqaFgZmHA7PXQ9tIih28sZKHnfKrsv4rvjTuPy34ywhxur5lra1UpL6wEjK9O+MUf8d/+KXmYVgxt400iPWWq5jtcKRLmKdtLF41Zaktp8Hca+w2Cy7i1kzJ1JhHqpJni+WOTepR+9RxPBnFblLS8aSOmjnOnN3+RLsu5qbqDDtQFSPrgXXlQpJj5sq0mqs4/BqbvOkKf5hpnkwzmIm564p0PTIroizqUtxyFkEt652Ia6fONLLWcKhYbISIauOzcTzpxck9SlztPYIsS5iaJvWo2d5enCjOM5uiZzWg462mRS1mrjazFfgU80wInluXqqetUmWTlHWdSFWcFudtcIxgptgyyZyPxPlYka31FdpR3WhcKEfysaOyNe1rsG0xHWiSdufSx5W8o7N/efYEvKOey8k+iEp3MoUg3PPzjS2yfti/oU3iWfayXauQvxOyg08qSsvHq2iLyrSjKk1bpqJ8UdE2NY0RKrqSbK/5+IiuYmRPwE54vJyoORmGii9U1D7W8mhCci/bGjl86DsYKpaszVFyk88qnihnvlUs8ewbJ8WPfquY19TearEVHTWy/7Sa9b4cbQoRsls4VHyrot24yvT3T7aKdnPs+wGoHBU1WK9lt83PKkZUn4GoHBWtOO1vX3a72d0qmkm4VDc1d9ctskfFSTT2zLXslsteChX/P373NSgAFQEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAKB/rPsndGZM+fwAAAABJRU5ErkJggg=="/></div><div class="graphic_lgnd">Seventy-two heart transplant recipients were randomly assigned to simvastatin or placebo and followed for four years; then all patients were maintained on simvastatin for another four years. Survival at eight years was significantly better for those patients who were treated with simvastatin throughout the eight-year course (89 versus 60 percent).</div><div class="graphic_reference">Data from Wenke K, Meiser B, Thiery J, et al. Circulation 2003; 107:93.</div><div id="graphicVersion">Graphic 60917 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
